Table 1.
Demographics and cancer-related characteristics by study medication adherence status
| Nonadherent (n=23) | Adherent (n=96) | ||||
|---|---|---|---|---|---|
| Variable | N or M | (% or SD) | N or M | (% or SD) | p-value |
| Female, % | 12 | (52%) | 47 | (49%) | 0.782 |
| White, % | 13 | (57%) | 72 | (75%) | 0.078 |
| Age (years) | 58.6 | (9.0) | 59.4 | (8.4) | 0.712 |
| < College graduate, % | 14 | (61%) | 61 | (64%) | 0.812 |
| Employed, % | 11 | (48%) | 47 | (49%) | 0.922 |
| Years smoking | 40.9 | (8.9) | 40.9 | (10.4) | 0.981 |
| FTCD score | 4.7 | (2.5) | 4.4 | (2.1) | 0.673 |
| Tobacco-related cancer site,a % | 18 | (78%) | 77 | (80%) | 0.834 |
| Cancer stage | 0.223 | ||||
| Stage 0–2 | 6 | (26%) | 18 | (19%) | |
| Stage 3–4 | 6 | (26%) | 14 | (15%) | |
| Remission/not reported | 11 | (48%) | 64 | (67%) | |
| Current cancer treatment,b % | 7 | (30%) | 40 | (42%) | 0.375 |
| Chemotherapy | 3 | (13%) | 20 | (21%) | |
| Radiation treatment | 1 | (4%) | 7 | (7%) | |
| Surgery | 3 | (13%) | 12 | (13%) | |
| Hormone therapy | 2 | (9%) | 10 | (10%) | |
p-values indicate significance of differences between adherent vs. nonadherent sample by t-tests (continuous variables) or chi-square analyses (categorical variables).
a
Participants’ cancer types included: genitourinary (n=29), breast (n=20), skin (n=19), lung (n=16), hematological (n=15), head and neck (n=8), gastrointestinal (n=6), and kidney/pancreatic/liver (n=6).
b
Cancer treatments (chemotherapy, radiation treatment, surgery, and hormone therapy) are not mutually exclusive.